Succeeded
|
The impact of COVID-19 on pregnancy treatment pathways and outcomes
|
main_pregnancy_tx_pathways
|
Vicki Palin UoM
|
8/8
|
TPP
|
07 May 2024
at
18:24
07 May 2024 18:24:04 UTC
|
View
|
Succeeded
|
The impact of COVID-19 on pregnancy treatment pathways and outcomes
|
main_pregnancy_tx_pathways
|
Vicki Palin UoM
|
10/10
|
TPP
|
07 May 2024
at
18:23
07 May 2024 18:23:21 UTC
|
View
|
Succeeded
|
The impact of COVID-19 on pregnancy treatment pathways and outcomes
|
main_pregnancy_tx_pathways
|
Vicki Palin UoM
|
7/7
|
TPP
|
07 May 2024
at
18:16
07 May 2024 18:16:41 UTC
|
View
|
Succeeded
|
Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19
|
prophy_effects_sotro_molnup
|
Qing Wen
|
2/2
|
TPP
|
07 May 2024
at
16:59
07 May 2024 16:59:53 UTC
|
View
|
Succeeded
|
Investigating events following SARS-CoV-2 infection
|
post-covid-autoimmune-v3
|
Jose Ignacio Cuitun Coronado
|
1/1
|
TPP
|
07 May 2024
at
16:08
07 May 2024 16:08:51 UTC
|
View
|
Succeeded
|
The impact of COVID-19 on pregnancy treatment pathways and outcomes
|
main_pregnancy_tx_pathways
|
Vicki Palin UoM
|
1/1
|
TPP
|
07 May 2024
at
15:15
07 May 2024 15:15:05 UTC
|
View
|
Succeeded
|
The impact of COVID-19 on pregnancy treatment pathways and outcomes
|
main_pregnancy_tx_pathways
|
Vicki Palin UoM
|
1/1
|
TPP
|
07 May 2024
at
12:28
07 May 2024 12:28:17 UTC
|
View
|
Succeeded
|
OpenSAFELY Internal
|
tpp-database-schema
|
Dave Evans
|
3/3
|
TPP
|
07 May 2024
at
10:49
07 May 2024 10:49:30 UTC
|
View
|
Succeeded
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
1/1
|
TPP
|
06 May 2024
at
17:27
06 May 2024 17:27:10 UTC
|
View
|
Succeeded
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
4/4
|
TPP
|
06 May 2024
at
14:12
06 May 2024 14:12:45 UTC
|
View
|
Succeeded
|
The impact of COVID-19 on pregnancy treatment pathways and outcomes
|
main_pregnancy_tx_pathways
|
Vicki Palin UoM
|
1/1
|
TPP
|
06 May 2024
at
10:50
06 May 2024 10:50:46 UTC
|
View
|
Failed
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
43/44
|
TPP
|
06 May 2024
at
06:58
06 May 2024 06:58:15 UTC
|
View
|
Succeeded
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
1/1
|
TPP
|
05 May 2024
at
19:57
05 May 2024 19:57:00 UTC
|
View
|
Succeeded
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
1/1
|
TPP
|
05 May 2024
at
19:53
05 May 2024 19:53:25 UTC
|
View
|
Failed
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
3/4
|
TPP
|
05 May 2024
at
19:13
05 May 2024 19:13:25 UTC
|
View
|
Succeeded
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
47/47
|
TPP
|
05 May 2024
at
09:01
05 May 2024 09:01:10 UTC
|
View
|
Succeeded
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
8/8
|
TPP
|
04 May 2024
at
18:26
04 May 2024 18:26:55 UTC
|
View
|
Failed
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
3/5
|
TPP
|
04 May 2024
at
13:48
04 May 2024 13:48:29 UTC
|
View
|
Succeeded
|
Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19
|
prophy_effects_sotro_molnup
|
Qing Wen
|
2/2
|
TPP
|
04 May 2024
at
08:58
04 May 2024 08:58:36 UTC
|
View
|
Failed
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
42/45
|
TPP
|
04 May 2024
at
08:33
04 May 2024 08:33:36 UTC
|
View
|
Failed
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
49/52
|
TPP
|
04 May 2024
at
00:01
04 May 2024 00:01:50 UTC
|
View
|
Failed
|
Long-term kidney outcomes after SARS-CoV-2 infection
|
long_term_kidney_outcomes_after_covid
|
Viyaasan Mahalingasivam
|
1/50
|
TPP
|
03 May 2024
at
23:49
03 May 2024 23:49:50 UTC
|
View
|
Succeeded
|
Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19
|
prophy_effects_sotro_molnup
|
Qing Wen
|
1/1
|
TPP
|
03 May 2024
at
21:10
03 May 2024 21:10:39 UTC
|
View
|
Succeeded
|
Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19
|
prophy_effects_sotro_molnup
|
Qing Wen
|
1/1
|
TPP
|
03 May 2024
at
20:56
03 May 2024 20:56:42 UTC
|
View
|
Succeeded
|
Investigating events following SARS-CoV-2 infection
|
post-covid-autoimmune-v3
|
Michael Gulley
|
15/15
|
TPP
|
03 May 2024
at
17:08
03 May 2024 17:08:27 UTC
|
View
|